Category

Search Reports

Filters

Sub Category

Geography

Publish Date

Argentina Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteo....

Argentine Antirheumatic Drugs market was valued at US$879.042 million in 2019. The rise in the number of patients suffering from chronic diseases including cardiovascular diseases is witnessing continuous growth in Argentina. According to the World Health Organization, the total prevalence of diabetes in Argentina is 10.2% of the country’s total population. The prevalence of these types of chronic diseases in Argentina is leading to a rise in the number of patients suffering from a Read more...

$2200 Sample Request

Canada Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoart....

Canada Antirheumatic Drugs market was valued at US$684.940 million in 2019. The growing aging population in Canada is the major factor that is driving the demand for antirheumatic drugs in the country. According to Statistics Canada, there are 5.9 million Canadian senior citizens as compared to 5.8 million Canadians who are 14 and under. According to the data provided by the Government of Canada, almost one in seven Canadians was above 65 in 2012 which is projected to rise to nearly one Read more...

$2200 Sample Request

China Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoarth....

China antirheumatic drugs market was valued at US$17,516.041 million in 2019. A growing number of patients suffering from arthritis in China is the major driver of the antirheumatic drugs market in the country.  According to the data from the Osteoarthritis Research Society International, its 2018 report showed that more than 8 percent of the total Chinese population is living with physician-diagnosed symptomatic knee OA while the prevalence of any type of arthritis/rheumatism was a Read more...

$2200 Sample Request

Europe Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoart....

The European antirheumatic drugs market was valued at US$8,038.148 million in 2019. The antirheumatic drugs market in the European region is expected to grow substantially over the course of the next five years. The major factors that are driving the market growth throughout the region include the moderate incidence of numerous rheumatic diseases in various countries of the region. Furthermore, the presence of the state-of-art pharmaceutical industry in major countries of the European re Read more...

$2600 Sample Request

Germany Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoar....

Germany antirheumatic drugs market as valued at US$1,382.401 million in 2019. The antirheumatic drug market in Germany is projected to show a nominal growth over the course of the next five years due to the growing geriatric population along with the presence of a well-established healthcare sector in the country. The booming healthcare expenditure in the country is also bolstering the anti-rheumatic drug market growth in the country throughout the forecast period. As per the data from t Read more...

$2200 Sample Request

India Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoarth....

India Antirheumatic Drugs market was valued at US$15,727.680 million in 2019. Increasing the prevalence of chronic diseases such as obesity and diabetes one of the major factors that is boosting the market growth of the antirheumatic drugs market in India. According to the World Bank Group, the prevalence of diabetes among individuals aged between 20 and 79 was 10.39% in 2017. This means that number of individuals hit by diabetes was around 139.12 million which was nearly 3% more than th Read more...

$2200 Sample Request

Israel Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoart....

Israel antirheumatic drugs market was valued at US$143.570 million in 2019. The market in Israel is poised to show decent growth over the course of the next five years due to rapid growth in the private healthcare spending of the country which is further anticipated to drive the demand for numerous treatments, medical services, and medicines among others. According to data by the Israel Central Bureau of Statistics, the proportion of private spending reached 40%, thus indicating a rise i Read more...

$2200 Sample Request

Japan Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoarth....

Japan antirheumatic drugs market was valued at US$1,353.154 million in 2019. The market growth is majorly being driven by the continuously increasing elderly population in this country. According to the World Bank Group data, the percentage of the total population, age 65 and above, has increased from 16.98% in 2000 to 27.58% in 2018 in this country. The state-of-the-art healthcare system in this country is contributing to this growing number, which, as a result, is increasing the burden Read more...

$2200 Sample Request

Middle East and Africa (MEA) Anti-Rheumatic Drug Market industry report focuses on the current marke....

The Middle East and Africa (MEA) antirheumatic drugs market was valued at US$10,727.154 million in 2019. The market in the Middle East and Africa region is poised to show healthy growth throughout the forecast period primarily on account of the presence of a well-established and state-of-art pharmaceutical industry in the region. The presence of a vast number of domestic pharmaceutical manufacturing companies is also considered to be a major factor driving the antirheumatic drugs market Read more...

$2600 Sample Request

North America Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (O....

North America Antirheumatic Drugs market was valued at US$8,988.317 million in 2019. The booming aging population in countries like the United States and Canada is the major driver of the antirheumatic drugs market in this region. According to the United States Census Bureau, all baby boomers will be older than age 65 by 2030, expanding the size of the older population such that 1 in every 5 residents will be at retirement age. According to the data provided by the Government of Canada, Read more...

$2600 Sample Request
TOTAL RESULTS: 766

OUR CLIENTS